Subscribe
epobuilding2
Photo: Courtesy of EPO
9 November 2018Biotechnology

EPO revokes Bayer broccoli patent

The European Patent Office (EPO) has revoked a Bayer-owned patent which covers a type of broccoli adapted to make their harvesting easier.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
Activist group opposes lettuce patent
7 March 2019   Activist group No Patents on Seeds has filed an opposition against a patent on lettuce, owned by Dutch food supplier Rijk Zwaan Zaadteelt.
Big Pharma
Senior counsel at Bayer highlights pharmaceutical TM challenges
15 March 2019   Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.
Big Pharma
Bayer, Apotex settle suit over cancer drug patent
13 August 2020   Bayer has settled a patent infringement suit with generics manufacturer Apotex, after claiming that its version of a cancer treatment infringed two patents.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Biotechnology
Activist group opposes lettuce patent
7 March 2019   Activist group No Patents on Seeds has filed an opposition against a patent on lettuce, owned by Dutch food supplier Rijk Zwaan Zaadteelt.
Big Pharma
Senior counsel at Bayer highlights pharmaceutical TM challenges
15 March 2019   Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.
Big Pharma
Bayer, Apotex settle suit over cancer drug patent
13 August 2020   Bayer has settled a patent infringement suit with generics manufacturer Apotex, after claiming that its version of a cancer treatment infringed two patents.

More on this story

Biotechnology
Activist group opposes lettuce patent
7 March 2019   Activist group No Patents on Seeds has filed an opposition against a patent on lettuce, owned by Dutch food supplier Rijk Zwaan Zaadteelt.
Big Pharma
Senior counsel at Bayer highlights pharmaceutical TM challenges
15 March 2019   Doctors’ handwriting poses a significant challenge to the registration of pharmaceutical trademarks, according to a senior counsel at German pharmaceutical company Bayer.
Big Pharma
Bayer, Apotex settle suit over cancer drug patent
13 August 2020   Bayer has settled a patent infringement suit with generics manufacturer Apotex, after claiming that its version of a cancer treatment infringed two patents.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott